TrialCancer2018

Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.

John V Hegde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.